The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Discover effective supplements for migraine prevention and learn who should or shouldn't use them. Explore evidence-based ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

If a triptan is ineffective, a different one should be tried before switching to a different ... Headache with the features of migraine without aura usually follows the aura symptoms.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

I've had my aura read twice before, but never in a fitness setting. The first time was on a trip to Sedona, AZ, which ...

Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.In the 7MM, the 12-month total prevalent cases of migraine are expected to increase from 74,226,117 cases in ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings ...

Migraines can be debilitating, but these inflammation-fighting lifestyle changes could help. Anyone who's experienced a ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.